About Selank - Neuro Anti Anxiety Peptide

Selank is a nootropic peptide derived from the immune molecule tuftsin that acts as a powerful, non-sedating anti-anxiety tool. It calms stress and mental chatter by regulating neurotransmitters like serotonin and dopamine, while boosting BDNF to keep your memory and focus sharp.

WHAT THE RESEARCH SHOWS

Research on Selank a synthetic peptide derived from the human immunopeptide tuftsin focuses heavily on its role as a "nootropic anxiolytic" (reducing stress while actually sharpening the mind). Here is what the clinical and preclinical studies show:
* Anxiety Relief Without Sedation: Selank modulates the GABAergic system to significantly lower generalized anxiety, stress, and panic. Clinical trials (primarily conducted in Russia, where it is approved) found its anxiolytic effects rivaled traditional medications like benzodiazepines, but with zero sedation, muscle relaxation, or risk of dependence.
* Boosts BDNF (Brain Plasticity): Studies show it increases the expression of Brain-Derived Neurotrophic Factor (BDNF) in the hippocampus, which aids in cellular repair, memory formation, and neuroplasticity.
* Neurotransmitter Balance: It helps regulate the turnover and balance of serotonin and dopamine, leading to better mood stability, emotional resilience, and sustained mental focus under high pressure.
* Immune Support: Because it is an analogue of tuftsin, research shows it acts as an immune modulator, helping suppress systemic inflammation and balance cytokine levels. It is most commonly administered as an intranasal spray (or subQ) and is frequently paired with Semax for a balanced calm-and-focus stack.

STUDIES

• Main trial that supported approval (2008). This randomised comparative trial (Zozulia, Neznamov and colleagues) treated 62 people with GAD or neurasthenia: 30 got Selank and 32 got medazepam, a benzodiazepine. Both reduced anxiety similarly, but Selank also reduced fatigue and had a mildly stimulating effect.
  • People with anxiety had low levels of an enkephalin (one of the body’s natural opioid-like calming chemicals). Selank raised those levels, and the rise tracked with improvement in anxiety.
  • This trial formed part of the evidence Russian regulators used to approve it.
• Fast response in some people (2012, European Psychiatry abstract). In 20 people with GAD given Selank as a nasal spray, 40% responded rapidly, with symptoms dropping sharply within 1–3 days. Their average anxiety score fell from 20.3 to 7.0 by day 3.
• Compared with phenazepam (2014). A trial against phenazepam, another benzodiazepine, in 60 people with anxiety-related disorders found Selank reduced anxiety, had mild nootropic (cognition-supporting) effects, and its benefit lasted about a week after the last dose.
• Immune effects. A small human study found changes in immune markers in people with anxiety and fatigue disorders, in line with Selank’s tuftsin origins.
• Fewer typical benzodiazepine downsides reported. Russian clinical studies describe anxiety relief similar to benzodiazepines, but without sedation, cognitive impairment or dependence.

LINKS

• Superpower – Selank guide (clinical trials)
• Superpower – Selank guide (Medvedev 2014)
• Syunyakov et al. 2012 – Rapid response in GAD (Cambridge)
• Selank study summaries (SciSpace)
• Dr Lewis – Selank for anxiety

Lyophilised powder